Percentage of Penicillin Non-Susceptible S

Slides:

Advertisements

Similar presentations

Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada:

Advertisements

Antimicrobial resistance surveillance in Ireland Results of invasive Streptococcus pneumoniae infection (blood/CSF) surveillance (2009Q1-4) **** Data as.

The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.

Choosing Antimicrobials in Special Situations. Additional considerations in making a final antibiotic selection Site of action – (Will the antibiotic.

Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME

Antimicrobial Resistance in N. gonorrhoeae: In Brief 2014 INTRODUCTION Increased action is needed to help prevent and control gonorrhea. Worldwide antimicrobial.

The Antimicrobial Resistance Surveillance Programme of Vietnam: Acute respiratory tract infections Do khang Chien, MD, PhD Nguyen thi phuong cham, BSPh.

Is Resistance Futile? Donald E Low University of Toronto Ontario Agency for Health Protection and Promotion.

Performance of Fox 10 Vs Staph. aureus DHM (Sydney), Gribbles (Melb.) Used Fox 10 since Jan 05 (> 1000) Borderline strains tested for mecA gene Results:

Overview of Use of PK-PD in Streamlining Drug Development William A. Craig Professor of Medicine University of Wisconsin.

Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention.

Toronto Invasive Bacterial Diseases Network  Collaborative network of all hospital and largest private microbiology laboratories in metropolitan Toronto/Peel.

Infertility Prevention Project Region I June 1, 2009 Wells Beach, Maine Infertility Prevention Project Region I June 1, 2009 Wells Beach, Maine Steven.

Trevor Winstanley Rebecca Clarke Department of Microbiology

PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.

Epidemiology of invasive meningococcal disease in the Netherlands and impact of serogroup C vaccination National surveillance data (Netherlands Reference.

Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.

Streptococcus pneumoniae Lecture 9 Summer, 2004 Demosthenes Pappagianis, MD MMI 480B.

Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.

Created byInformation Design A Mathematical Model for the Impact of the Conjugate Vaccine on S. pneumoniae Vaccine and Non-vaccine serotypes Robertino.

 decimals/cc-7th-fracs-to-decimals/v/converting-fractions-to-decimals-example.

Susceptibility Patterns over 3 years in Community-acquired Lower Respiratory Infection in the UK and Ireland R. Reynolds, D. Felmingham BSAC Working Party.

Antimicrobial Resistance in Streptococcus pneumoniae Implications for Prescription Drug Labeling John H. Powers, MD Lead Medical Officer Antimicrobial.

Nosocomial E. coli Urine Isolates 1991 – Nosocomial K. pneumoniae Urine Isolates

Nosocomial E. coli Urine Isolates Nosocomial K. pneumoniae Urine Isolates

K. Loens, E. De Herdt, S. Verkroost, C. Lammens, M. Ieven and H. Goossens Surveillance of invasive Group A Streptococci in Belgium (01/01/ /12/2014)

Ocular TRUST 3: Ongoing Longitudinal Surveillance of Antimicrobial Susceptibility in Ocular Isolates Penny A. Asbell, MD, FACS, MBA 1 ; Daniel F. Sahm,

Tuberculosis in the United States

Figure 1. Rate of antimicrobial resistance in S. pneumoniae

Figure 1. Percentage of Penicillin Non-Susceptible S

Toronto Invasive Bacterial Diseases Network

Bacterial superinfection of chicken pox: Best antibiotic to use?

EARS-Net data on Antimicrobial Resistance in Ireland, Q

* LABORATORY-BASED SURVEILLANCE OF S. PNEUMONIAE INVASIVE DISEASE (IPD) IN CHILDREN: SEROTYPE DISTRIBUTION AND ESTIMATION OF VACCINES COVERAGE B. V. M.

Gonococcal Isolate Surveillance Project (GISP)

Ontario’s Pneumococcal Vaccination Program Allison McGeer

Toronto Invasive Bacterial Diseases Network

Ontario Group A Streptococcal Study

C-672b First report of Group B Streptococcus Isolates with Cross-resistance to Lincosamides, Streptogramin A, and Pleuromutilins in the United States P.

at George Washington University Medical Center, Washington, DC

Antibiotic resistance and serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae from children in Marrakech region (Morocco) Karima.

Tuberculosis in the United States

Population Mini Census

R. Leclercq Clinical Microbiology and Infection

Gonorrhea Sexually Transmitted Disease Surveillance 2010

Ketolides: A New Class of Antibacterial Agents for Treatment of Community-Acquired Respiratory Tract Infections in a Primary Care Setting Jeffrey Paul.

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

The State of Pneumococcal Disease Prevention

Saskatchewan Geography

Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media Fernando Baquero, Rafael Cantón, Fernando.

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program M.

Pneumococcal conjugate vaccines: overview of a decade from Kuwait

D.E. Low Clinical Microbiology and Infection

…monitoring trends in antimicrobial resistance in Canada

Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern.

Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage Ron Dagan, Drora Fraser, Noga Givon, Pablo.

M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

Figure 1. Percentage of Penicillin Non-Susceptible S

ANTIMICROBIAL USE AND RESISTANCE SURVEILLANCE PILOT PROJECT – LESSONS FROM THE DURBAN SITE Gray AL, Essack SY, Deedat F, Pillay T, van Maasdyk J, Holloway.

Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model Karl Ekdahl, Otto Cars Clinical Microbiology.

The prevalence of penicillin-non-susceptible Streptococcus pneumoniae among children aged < 5 years correlates with the biannual epidemic activity of.

…monitoring trends in antimicrobial resistance in Canada

M. Biçmen, Z. Gülay, S.V. Ramaswamy, D.M. Musher, D. Gür

Modification of prescribers’ behavior: the Icelandic approach

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

…monitoring trends in antimicrobial resistance in Canada

…monitoring trends in antimicrobial resistance in Canada

…monitoring trends in antimicrobial resistance in Canada

Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.

Presentation transcript:

Percentage of Penicillin Non-Susceptible S Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: 1988-2008 *Oral breakpoints used Canadian Bacterial Surveillance Network, Feb 2009

Percentage of Non-susceptible Sterile Site vs Non-sterile Site Isolates of S. pneumoniae, 2008 Canadian Bacterial Surveillance Network, Jan 2009

Percentage of Amoxicllin Non-Susceptible S Percentage of Amoxicllin Non-Susceptible S. pneumoniae in Canada: 1988-2008 *Non-meningitis breakpoints used Canadian Bacterial Surveillance Network, Feb 2009

Percentage of Non-susceptible Isolates of S Percentage of Non-susceptible Isolates of S. pneumoniae in Ages <=15 and >64, 2008 Canadian Bacterial Surveillance Network, Jan 2009

Percentage of Non-susceptible Isolates of S Percentage of Non-susceptible Isolates of S. pneumoniae in Geographic Regions of Canada, 2008 Canadian Bacterial Surveillance Network, Feb 2009

Macrolide-Resistant Pneumococci: Canadian Bacterial Surveillance Network, 1988-2008 Canadian Bacterial Surveillance Network, Feb 2009

Fluoroquinolone-Resistant Pneumococci: Canadian Bacterial Surveillance Network, 1997-2008 Canadian Bacterial Surveillance Network, Jan 2009

Fluoroquinolone-Resistant Pneumococci in Respiratory Isolates from Adults >64 years: 1988-2008

Ceftriaxone-Resistant Pneumococci: Canadian Bacterial Surveillance Network, 1988-2008 *Non-meningitis breakpoints used Canadian Bacterial Surveillance Network, Feb 2009